课题基金 / 基金详情

ORAL L GLUTAMINE THERAPY FOR SICKLE CELL ANEMIA

ORAL L GLUTAMINE THERAPY FOR SICKLE CELL ANEMIA
口服 L 谷氨酰胺治疗镰状细胞贫血症
批准号：
6264882
负责人：
YUTAKA NIIHARA
金额：
$0.1万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6264882
关键词：
blood disorder chemotherapy clinical research erythrocytes glutamine human subject human therapy evaluation sickle cell anemia

项目摘要

项目成果

YUTAKA NIIHARA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To test the effects of glutamine on red blood cells of patients with Sickle Cell Anemia. Glutamine is a component of protein and is a part of a person's normal diet. It is often used as a nutritional supplement or as medication for various medical problems such as intestinal problems
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: L-GLUTAMINE THEREPY FOR SICKLE CELL ANEMIA
L-GLUTAMINE THERAPY FOR SICKLE CELL ANEMIA
CLINICAL TRIAL: L-GLUTAMINE THEREPY FOR SICKLE CELL ANEMIA
L-GLUTAMINE THERAPY FOR SICKLE CELL ANEMIA
海外基金